跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-CALCIPOTRIOL / BETAMETHASONE GEL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
Authorized
STANDARD
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ced141fae78d7ab1
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
ced141fae78d7ab1
Drug Approval Canada Name
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
Product Name
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
Status
Marketed
Status Date
2022-06-01
Original Market Date
2022-06-01
Din
02525178
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:06.00
Atc Original
D05AX52 CALCIPOTRIOL, COMBINATIONS
Atc Name
d 05 ax 52
Aig Number
0252270002
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
BETAMETHASONE (BETAMETHASONE DIPROPIONATE)
0.5 MG / G
CALCIPOTRIOL (CALCIPOTRIOL MONOHYDRATE)
50 MCG / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ced141fae78d7ab1
Type
Standard
Back to Health Canada Approvals